Joanna Hockenhull1, Kevin G Murphy2, Sue Paterson3. 1. Toxicology Unit, Imperial College London, St. Dunstan's Road, London W6 8RP, UK. Electronic address: j.hockenhull@imperial.ac.uk. 2. Section of Endocrinology and Investigative Medicine, Imperial College London, Commonwealth Building, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. 3. Toxicology Unit, Imperial College London, St. Dunstan's Road, London W6 8RP, UK.
Abstract
BACKGROUND: Gamma-hydroxybutyrate (GHB) is the drug most linked to acute harm out of those used in chemsex, the incidence of which is reported to be increasing. However, there have been few systematic studies of the harms associated with GHB use. We investigated GHB-associated deaths from London coroners' jurisdictions between 2011 and 2015. METHODS: Blood and urine samples were collected by pathologists and submitted for toxicological analysis at the request of coroners. Data from the Toxicology Unit, Imperial College London was retrospectively analysed. This comprised of 6633 cases from seven out of eight coroners' jurisdictions in London that underwent toxicological analysis between January 2011 and December 2015. RESULTS: A total of 61 GHB-associated deaths (0.92% of total cases), 184 cocaine-associated deaths (2.8% of total cases) and 83 MDMA-associated deaths (1.3% of total cases) were identified. There was a 119% increase in the proportion of GHB-associated deaths detected in 2015 compared to 2014. Over the same time period there was a 25% increase in cocaine-associated deaths and a 10% decrease in MDMA-associated deaths. CONCLUSIONS: Our data suggest that GHB-associated deaths are increasing in London, and that this is likely at least in part due to increasing use of GHB for chemsex. Further studies on the use of GHB are urgently required to understand the extent of its use, whether this is as prevalent in other major urban areas in the UK, and the full extent of the harms it causes.
BACKGROUND:Gamma-hydroxybutyrate (GHB) is the drug most linked to acute harm out of those used in chemsex, the incidence of which is reported to be increasing. However, there have been few systematic studies of the harms associated with GHB use. We investigated GHB-associated deaths from London coroners' jurisdictions between 2011 and 2015. METHODS: Blood and urine samples were collected by pathologists and submitted for toxicological analysis at the request of coroners. Data from the Toxicology Unit, Imperial College London was retrospectively analysed. This comprised of 6633 cases from seven out of eight coroners' jurisdictions in London that underwent toxicological analysis between January 2011 and December 2015. RESULTS: A total of 61 GHB-associated deaths (0.92% of total cases), 184 cocaine-associated deaths (2.8% of total cases) and 83 MDMA-associated deaths (1.3% of total cases) were identified. There was a 119% increase in the proportion of GHB-associated deaths detected in 2015 compared to 2014. Over the same time period there was a 25% increase in cocaine-associated deaths and a 10% decrease in MDMA-associated deaths. CONCLUSIONS: Our data suggest that GHB-associated deaths are increasing in London, and that this is likely at least in part due to increasing use of GHB for chemsex. Further studies on the use of GHB are urgently required to understand the extent of its use, whether this is as prevalent in other major urban areas in the UK, and the full extent of the harms it causes.
Authors: Tenille C Taggart; Craig Rodriguez-Seijas; Christina Dyar; Jennifer C Elliott; Ronald G Thompson; Deborah S Hasin; Nicholas R Eaton Journal: Behav Res Ther Date: 2018-12-24
Authors: Ada R Miltz; Fiona C Lampe; Loraine J Bacchus; Sheena McCormack; David Dunn; Ellen White; Alison Rodger; Andrew N Phillips; Lorraine Sherr; Amanda Clarke; Alan McOwan; Ann Sullivan; Mitzy Gafos Journal: BMC Public Health Date: 2019-04-25 Impact factor: 3.295
Authors: Janey Sewell; Valentina Cambiano; Ada Miltz; Andrew Speakman; Fiona C Lampe; Andrew Phillips; David Stuart; Richard Gilson; David Asboe; Nneka Nwokolo; Amanda Clarke; Graham Hart; Alison Rodger Journal: Sex Transm Infect Date: 2018-04-26 Impact factor: 3.519
Authors: Isabel A L Slurink; Birgit H B van Benthem; Martijn S van Rooijen; Roel C A Achterbergh; Fleur van Aar Journal: Sex Transm Infect Date: 2019-06-20 Impact factor: 3.519